BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Willmann J, Rimner A. The expanding role of radiation therapy for thymic malignancies. J Thorac Dis. 2018;10:S2555-S2564. [PMID: 30206499 DOI: 10.21037/jtd.2018.01.154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rico M, Flamarique S, Casares C, García T, López M, Martínez M, Serrano J, Blanco M, Hernanz R, de Ingunza-Barón L, Marcos FJ, Couñago F. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours. World J Clin Oncol 2021; 12(4): 195-216 [PMID: 33959475 DOI: 10.5306/wjco.v12.i4.195] [Reference Citation Analysis]
2 Tateishi Y, Horita N, Namkoong H, Enomoto T, Takeda A, Kaneko T. Postoperative Radiotherapy for Completely Resected Masaoka/Masaoka-Koga Stage II/III Thymoma Improves Overall Survival: An Updated Meta-Analysis of 4746 Patients. J Thorac Oncol 2021;16:677-85. [PMID: 33515812 DOI: 10.1016/j.jtho.2020.12.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fan XW, Yang Y, Wang HB, Xu Y, Kang M, Xie LY, Li L, Fang WT, Zhao KL, Chen HQ, Xiang JQ, Ung YC, Wong CS, Jiang GL, Wu KL. Intensity Modulated Radiation Therapy Plus Etoposide/Cisplatin for Patients With Limited Advanced Unresectable Thymic Epithelial Tumors: A Prospective Phase 2 Study. Int J Radiat Oncol Biol Phys 2020;107:98-105. [PMID: 31987968 DOI: 10.1016/j.ijrobp.2019.12.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Diwanji T, Sawant A, Sio TT, Patel NV, Mohindra P. Proton stereotactic body radiation therapy for non-small cell lung cancer. Ann Transl Med 2020;8:1198. [PMID: 33241047 DOI: 10.21037/atm-20-2975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 He DC, Zhu ZJ, Zhang XY, Zhang Y, Hong J, Shi TT, Han JH. Dosimetric analysis of postoperative radiotherapy for thymoma. Cancer Radiother 2021:S1278-3218(21)00253-5. [PMID: 34728117 DOI: 10.1016/j.canrad.2021.07.037] [Reference Citation Analysis]
6 Bakhos CT, Salami AC, Kaiser LR, Petrov RV, Abbas AE. Thymic Neuroendocrine Tumors and Thymic Carcinoma: Demographics, Treatment, and Survival. Innovations (Phila) 2020;15:468-74. [PMID: 32938293 DOI: 10.1177/1556984520949287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Rappaport JMP, Huang J, Ahmad U. Thymic Malignancy-Updates in Staging and Management. Surg Oncol Clin N Am 2020;29:581-601. [PMID: 32883460 DOI: 10.1016/j.soc.2020.06.010] [Reference Citation Analysis]
8 McGunigal M, Margolis M, Forsthoefel M, Singh T, Amarell K, Deblois D, Campbell L, Kim C, Liu S, Bergquist PJ, Debrito P, Collins BT, Giaccone G, Lischalk JW. Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience. Acta Oncol 2021;60:649-52. [PMID: 33629926 DOI: 10.1080/0284186X.2021.1887516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Süveg K, Putora PM, Joerger M, Iseli T, Fischer GF, Ammann K, Glatzer M. Radiotherapy for thymic epithelial tumours: a review. Transl Lung Cancer Res 2021;10:2088-100. [PMID: 34012817 DOI: 10.21037/tlcr-20-458] [Reference Citation Analysis]
10 Franceschini D, Cozzi L, Loi M, Franzese C, Reggiori G, Mancosu P, Clivio A, Fogliata A, Scorsetti M. Volumetric modulated arc therapy vs intensity-modulated proton therapy in the postoperative irradiation of thymoma. J Cancer Res Clin Oncol. 2020;146:2267-2276. [PMID: 32514629 DOI: 10.1007/s00432-020-03281-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]